Plant Health Care PLC New US PREtec Patents Issued
06 Octubre 2020 - 1:00AM
RNS Non-Regulatory
TIDMPHC
Plant Health Care PLC
06 October 2020
Reach
6 October 2020
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Four US patents issue for PRE tec peptide products
Plant Health Care (R) (AIM: PHC.L) , a leading provider of novel
patent-protected biological products to global agriculture markets,
is pleased to announce the granting of four new US patents for its
novel PRE tec peptide technology.
Highlights
- Plant Health Care has filed more than 50 patent applications
worldwide for its PRE tec peptide technology since 2012
- Four additional patents have now been granted by the US Patent
and Trademark Office (USPTO)
- The patents provide protection for a wide range of PRE tec
peptides for a variety of agricultural uses
- Additional patents are expected to be granted prior to the end
of the year
PREtec is a novel, environmentally friendly approach to growing
crops more sustainably. PREtec peptides can be thought of as
'vaccines for plants' - they stimulate the plants' natural defence
systems and result in improved crop yield and quality.
Three of the four patents share the same title, "Elicitor
Peptides Having Disrupted Hypersensitive Response Box And Use
Thereof," and issued January 7, 2020, as U.S. patent No. 10,524,472
and U.S. patent No. 10,524,473, and on August 18, 2020, as U.S.
patent No. 10,743,538. The fourth patent, titled "Hypersensitive
Response Elicitor-Derived Peptides And Use Thereof," issued on
October 6, 2020, as U.S. patent No. 10,793,608.
These patents, in addition to US patent No. 10,470,461 which
issued in 2019, claim a large number of unique plant response
elicitor peptides that when applied activate a plant to defend
itself, thereby ' vaccinating ' plants against a variety of
environmental stresses such as disease and drought, enhancing root
and shoot growth, and promoting yield and crop quality at
harvest.
For example, in almond trials conducted in California during the
2018 and 2019 growing seasons, the application of a PRE tec peptide
resulted in increasing the almond yield by more than fifteen
percent compared to the standard practices. At recent almond
prices, this additional yield would have been worth more than
$800/acre to the grower. Multiple foreign patents corresponding to
these US PRE tec patents are expected to issue during the next
12-24 months.
As previously announced, the Company is now poised to launch the
first products from a broad pipeline of PREtec peptides, targeting
markets which have a value of greater than $5 billion. The Company
has developed a global scientific lead in the use of plant response
elicitor peptides for agriculture, with a number of patents now
granted in the US.
Chris Richards, CEO of Plant Health Care, said, "Receiving these
new patents is another step towards securing Plant Health Care's
position as the leading innovator of peptides for agriculture. The
Company has developed a global scientific lead in the use of plant
response elicitor peptides for agriculture, with a number of
patents now granted in the US. These patents cover an immense
number of future product candidates which we are continuing to
develop to solve a variety of urgent problems faced by farmers. We
are preparing to launch this novel technology directly to markets
in USA, Brazil and other countries, once regulatory permits are in
place. The Company expects to begin the commercialization of
products based on PRE tec intellectual property in 2022. "
For further information, please contact:
Plant Health Care plc
Chris Richards, CEO, Tel: +1 919 926 1600
Arden Partners plc - Nomad & Broker
John Llewellyn-Lloyd / Dan Gee-Summons Tel: +44 (0) 20 7614
5900
Company website: www.planthealthcare.com
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute non-regulatory news releases into
the public domain. Information required to be notified under the
AIM Rules for Companies, Market Abuse Regulation or other
regulation would be disseminated as an RNS regulatory announcement
and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAELLFBBBLZFBQ
(END) Dow Jones Newswires
October 06, 2020 02:00 ET (06:00 GMT)
Plant Health Care (LSE:PHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Plant Health Care (LSE:PHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024